HYUNDAI BIOLAND Co.,Ltd.

052260KOSDAQChemicals and chemical products

HYUNDAI BIOLAND Co.,Ltd. (052260, KOSDAQ) reported KRW 131bn revenue in 2025.

Reported financials

Figures are as filed with the Korean regulator, in billions of won (KRW bn). We do not convert to dollars — an exchange rate would be a number we made up, not one the company reported.

YearRevenueOperating profitNet profitAssetsEquityBasis
202310278184136Consolidated
2024120166195138Consolidated
2025131130167136Consolidated

Ratios, year by year

Each ratio is computed inside its own year. A dash means the input was missing or the denominator was zero — not that the value is zero.

YearOperating marginNet marginEquity / assetsReturn on equity
20237%7.9%73.9%5.9%
202413.7%4.8%70.9%4.1%
20259.7%0.2%81.6%0.2%

Revenue moved 28.3% between 2023 and 2025.

These are arithmetic, not judgements. We do not say whether a margin is good or bad, and we do not rank companies against each other.

Market size

Market capitalisationKRW 118bn
Close priceKRW 3,920
Listed shares30,000,000
Price as of20260909

Market capitalisation is what buyers are betting the company is worth. It is not something the company produced, so we never present it as output or productivity.

Workforce — a side measure, not the main one

Employees (2025)342
Women92 (26.9%)
Average tenure8.8 years
Annual pay, menKRW 71,359,000
Annual pay, womenKRW 54,797,000
Pay ratio, women to men76.8%

Other companies in Chemicals and chemical products

172 listed companies file under this classification. Showing 12.

See the whole Chemicals and chemical products list →